|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, MetroHealth Medical Center and the Center for Academic Clinical Research, Case Western Reserve University School of Medicine, Cleveland, OH.
Correspondence to: E. R. McFadden, Jr, MD, Division of Pulmonary, Critical Care, and Sleep Medicine, MetroHealth Medical Center, 2500 MetroHealth Dr, Cleveland, OH 44109; e-mail: erm2{at}case.edu
| Abstract |
|---|
|
|
|---|
NO] with the amount of NO in equilibrium with the conducting airways (eNOair) and the amount of NO diffusing from the alveoli (eNOalv). Design: Observational study.
Setting: University teaching hospital.
Participants: Normal subjects.
Interventions: Measurements were made in 16 healthy people during and after 4 min of tidal breathing (10 L/min) and isocapnic hyperventilation of 60 L/min.
Measurements and results: FeNO was measured by collecting the exhaled air during the last minute of each trial and passing it through a chemiluminescence analyzer. The expired NO levels in the plateau phases of slow (30 mL/s) and fast (200 mL/s) single-breath exhalations were also obtained before and after hyperventilation. The VNO (mean ± SEM) increased from 89.8 ± 12.3 to 329.1 ± 36.2 nL/min as
E rose (p < 0.001). However, neither the quantities of eNOair nor eNOalv changed with hyperventilation (eNOair range before to after, 34.9 ± 7.7 to 30.9 ± 6.4 parts per billion [ppb], p = 0.96; eNOalv range before to after, 7.3 ± 1.5 to 6.5 ± 1.1 ppb, p = 0.97).
Conclusions: These data demonstrate that the amount of NO in equilibrium with the airway walls and alveoli are not altered by hyperpnea. Rather, the apparent augmentation in
NO in such circumstances appears to be an arithmetic artifact.
Key Words: hyperpnea isocapnic hyperventilation nitric oxide synthesis
| Introduction |
|---|
|
|
|---|
Most46789101112 but not all studies13 have suggested that the production of NO, as measured by minute ventilation (
E) times the fractional concentration of NO in the exhaled air (FeNO) [
NO], rises during exercise and hyperventilation. Since the magnitude of the increase, at least during physical exertion, correlates with carbon dioxide production, oxygen consumption, and heart rate, it has been assumed that NO augmentation is an important element in regulating these processes.46789101112 This may or may not be the case, however, for such correlations do not uniformly exist with voluntary hyperventilation.13 More importantly, it is unclear if the level of NO in the lungs actually changes whenever
E rises.13
To provide data on these issues, we made use of recently described diffusion models1415 to determine the amount of NO in equilibrium with the conducting airways (eNOair) and the amount of NO diffusing from the alveoli (eNOalv) before and after hyperpnea. We then contrasted these results with those seen when NO production is calculated in the standard manner.46789101112 Our observations form the basis of this report.
| Materials and Methods |
|---|
|
|
|---|
E of 10 L/min to standardize baseline conditions, and then performed isocapnic hyperventilation at 60 L/min using standard techniques.1617 Each period of ventilation lasted 4 min, during which time the expirate was directed into a reservoir balloon that was being constantly evacuated at a known rate through a calibrated rotameter into a dry gas meter.1617
E was controlled at the desired value by coaching the subjects to keep the balloon filled. The level of
E was then verified directly with the dry gas meter. End-tidal carbon dioxide concentrations were monitored during hyperventilation (Nellcor N-1000; Mallinckrodt; Kansas City, MO), and sufficient carbon dioxide was added to the inspiratory port of the exchanger to maintain end-tidal carbon dioxide at eucapnic levels.
Expired air was collected during the final minute of both the resting and hyperventilation trials in nondiffusing bags. The mouthpiece of the collecting system contained a fixed resistance of 5 cm H2O to close the soft palate and exclude nasal NO.18 The FeNO was recorded off-line by passing the exhaled gas through a chemiluminescence NO analyzer designed for physiologic measurements (CLD 77 AM; ECO Physics; Ann Arbor, MI).19 The system was calibrated with NO-free gas and a standard NO concentration of 15 parts per billion (ppb) [Praxair; Bethlehem, PA] daily before use. The linearity of the analyzer was verified with analytically certified gases of 0 ppb and 200 ppb NO (Scott Specialty Gases; Plumsteadville, PA). The detection limit was 1.1 ± 0.2 ppb (coefficient of variation [CV], < 1%) [mean ± SEM]. Ambient NO levels were recorded at the start and end of each experiment. If the levels on any given day were
20 ppb, no studies were undertaken. It has been our experience and that of others20 that ambient levels
15 ppb have little impact on expired NO (eNO) values. The output of the analyzer was fed into a time-based recorder (Omega Engineering, Inc., Stamford, CT) for display. The production of NO per minute (
NO) was calculated as the product of FeNO and
E.46789101112
Prior to each period of ventilation, immediately after the collection of exhaled gas and then again 5 min later, the subjects performed single-breath exhalations from total lung capacity to residual volume at flow rates of 30 mL/s and 250 mL/s through the NO analyzer to assess the quantities of eNOair and eNOalv.1415 The desired flows were achieved by attaching calibrated resistors (Restrictor Set HTF 5019X; Sievers Instruments; Boulder, CO) to the end of the mouthpiece and coaching the subjects to maintain a constant pressure for the length of the exhalation. During the low-flow and high-flow experiments, mouth pressures were monitored continuously and kept at 8 to 9 cm H2O and 14 to 15 cm H2O, respectively. The output from the NO analyzer was digitized and stored in a personal computer. During each maneuver, the sustained steady-state eNOair and eNOalv plateau concentrations were averaged electronically and the results verified manually. All exhalations were performed in duplicate, and CVs were calculated.
The protocol was approved by the Institutional Review Board for Human Investigation at MetroHealth Medical Center, and informed consent was obtained from each volunteer before participation. The data were analyzed by paired t tests and one-factor analyses of variance. A p value < 0.05 was considered significant.
| Results |
|---|
|
|
|---|
NO equaled 89.8 ± 12.3 nL/min. The control airway and alveolar plateau concentrations were 34.9 ± 7.7 ppb and 7.1 ± 1.1 ppb, respectively.
|
NO rose 266% to 329.1 nL/min (p < 0.001) [Fig 1
]. Airway and alveolar NO concentrations, however, did not materially change (Fig 2
).
|
|
Representative examples of the eNO patterns during the slow and fast exhalations are presented in Figure 3 . The eNOair plateaus during the 30 mL/s trials were sustained for an average of 36.1 ± 3.2 s (between-trials mean range, 35.0 ± 3.1 to 36.8 ± 2.9 s, p = 0.99; between-subject range, 20 to 59 s). The plateaus with the 250 mL/s maneuvers lasted approximately one third as long (11.7 ± 3.1 s) and were also highly reproducible (between-trials mean range, 11.4 ± 1.0 to 12.1 ± 1.1 s, p = 0.99; individual between-subject range, 7 to 21 s).
|
|
| Discussion |
|---|
|
|
|---|
NO appears to rise in such circumstances, it does so for mathematical rather than physiologic reasons. As the ventilatory component of the
E-NO relationship increases, eNO actually falls. However, since the magnitude of the change in
E far exceeds the decrement in NO, the product enlarges, giving the impression that production was up-regulated. Our data show that this is clearly an epiphenomenon. While it is occurring, there are no detectable changes in the concentration of NO in equilibrium with the airways or alveoli. The exchange dynamics of NO in the respiratory tract and its measurement in the exhaled air are complex. Unlike oxygen and carbon dioxide, NO is generated throughout the lungs as a free radical and reacts with a variety of substrates.221 As a result, the quantity exhaled represents the algebraic sum of the amounts produced minus those that are converted chemically or diffused away.1415 Both the alveoli and the conducting airways contribute to the exhaled concentrations, but do so in variable amounts. The level in the alveoli in adults is believed to be low because of the avid binding of NO with hemoglobin. In contrast, the quantities in the bronchi are considerably higher and fluctuate significantly in concert with the underlying physiologic state.221 During exhalation, the NO in the air stream leaving the alveoli is enriched by diffusion from the bronchial walls in direct proportion to the concentration gradients that exist and inversely with the velocity of the gas stream.1415 For any given gradient, the slower the flow, the higher the exhaled concentrations and the more eNO reflects the contribution from the airways. Alternatively, the faster the flow, the shorter the time for diffusion and the closer the eNO value is to alveolar levels.1415 Thus, if one is seeking to find a change in production in response to a given stimulus, it is critical that the before and after assessments be undertaken at identical flow rates. The data in Figures 2, 3 show that this requirement was readily achieved. Holding mouth pressure constant while exhaling through calibrated resistors produced highly reproducible steady-state NO elimination profiles.
The flows that we employed in the single-breath trials represent a simplification of the NO elimination model of Silkoff et al.15 The flow rates chosen to examine exhaled profiles fit nicely within the ranges thought to reflect the airway and alveolar components and were sustained sufficiently long to achieve highly reproducible steady-state values. The assumption we made was that, all else being equal, any up-regulation of NO synthesis would be manifest as an elevated plateau in the compartment in which it was generated.
We chose plateau values as representing net synthesis rather than determining flow independent parameters such as NO diffusion capacity, flux, or airway wall concentrations because of the temporal constraints imposed by our protocol. Since neither the site of any potential up-regulation nor the time course was known, we believed we needed to make serial measurements of airway and alveolar concentrations that could be completed in reasonably rapid succession from the end of hyperventilation. The use of the multiple slow flow rates required for the calculation of the above elements would have defeated our purpose. Because of the time necessary to complete such a protocol, we could never have been certain if NO synthesis was changing as we measured it.
Our data in both the multiple and single-breath analyses complement and extend previous studies.4678910111213 The
E-FeNO patterns recorded are typical of those reported in other trials with both hyperventilation11113 and exercise.67891222 High levels of
E (ie, three or more times resting levels) are typically associated with decrements in FeNO and computed increments in
NO of the magnitudes we observed. The eNO concentrations are also comparable to those in the literature. Silkoff et al15 noted steady-state eNOair concentrations between 42 ppb and 25 ppb at air flows of 21 mL/s and 38 mL/s, respectively. Similarly, St. Croix and associates13 found values between 36 ppb and 41 ppb at an exhaled flow of 46 mL/s. As can be seen in Figure 2, our data fall within the former ranges and lie quite close to the latter.
Like St. Croix and colleagues,13 we did not find that hyperpnea augmented NO synthesis. It is of interest that in their experiment, eNO did not rise with exercise or voluntary hyperventilation, but rather fell significantly. This finding suggests that production either decreased or that the before and after exhaled flow rates may not have been identical.1415 Our data do not support attenuation. We used a calibrated system with slower flow rates and lower mouth pressures to generate NO plateaus, but focused on hyperventilation. This route was chosen because isocapnic hyperventilation permits precise control over the respiratory patterns during and especially after hyperpnea. Unlike exercise, during which
E can remain elevated with short inspiratory times after exertion, particularly with high work loads because of continuing metabolic demands, hyperventilation can be stopped at will. As a result, our subjects could repeatedly perform the required flow maneuvers without being interrupted by the need to take a breath. Consequently, we could be confident that we were not inadvertently altering local events that controlled NO synthesis and elimination.
We appreciate that since we did not study all forms of hyperpnea, we cannot state with certitude that our results preclude an increase in NO production with exercise. However, we do not believe this to be the case. Others13 have examined this phenomenon by matching the ventilatory levels induced by physical exertion and voluntary hyperventilation and have not found any difference between them in the amount of NO generated in the tracheobronchial tree. Given that the thermal and mechanical effects of exercise and hyperventilation on the airways are identical when
E and the inspired air conditions are matched and carbon dioxide controlled, such findings are not surprising.16232425
In summary, hyperpnea is not associated with an increase in NO synthesis in either the conducting airways or alveoli. As a result, the suggestions in the literature that augmented NO production is linked to the cardiovascular, respiratory, and metabolic consequences of hyperpnea needs to be reevaluated.
| Footnotes |
|---|
E = minute ventilation;
NO = minute ventilation times the fractional expired nitric oxide concentration Supported in part by grants HL-33791 and HL-04140 from the National Heart, Lung, and Blood Institute and by General Clinical Research Center Grant MO1-RR00080 from the National Center for Research Resources, United States Public Health Services.
Received for publication April 25, 2005. Accepted for publication June 3, 2005.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |